Clinical Effectiveness-Implementation Hybrid Type 2 Study on Home-Delivered Cabenuva for People Living With HIV Who Are Not Retained in Care
Clinical trial NCT06062979 · UNKNOWN
Trial details
- NCT number
- NCT06062979
- Sponsor
- Whitman-Walker Institute
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-01
- Primary completion
- 2025-06-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.